Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03033511 |
|---|---|
| Brief Title: | A Study of Rovalpituzumab Tesirine as Maintenance Therapy Following First- Line Platinum-Based Chemotherapy in Participants With Extensive Stage Small Cell Lung Cancer (MERU) (MERU) |
| First Submitted : | January 25, 2017 |
| First Submitted that Met QC Criteria : | January 25, 2017 |
| First Posted : | January 26, 2017 (Estimate) |
| Last Update Submitted that Met QC Criteria : | December 4, 2019 |
| Last Update Posted : | December 5, 2019 |